Copyright Reports & Markets. All rights reserved.

Global Seasonal Affective Disorder Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Light Therapy (Phototherapy)
      • 1.4.3 Medication
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Seasonal Affective Disorder Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Seasonal Affective Disorder Therapeutics Market Size
    • 2.2 Seasonal Affective Disorder Therapeutics Growth Trends by Regions
      • 2.2.1 Seasonal Affective Disorder Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Seasonal Affective Disorder Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Seasonal Affective Disorder Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Seasonal Affective Disorder Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Seasonal Affective Disorder Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Seasonal Affective Disorder Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Seasonal Affective Disorder Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Seasonal Affective Disorder Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Seasonal Affective Disorder Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
    • 5.2 Seasonal Affective Disorder Therapeutics Key Players in United States
    • 5.3 United States Seasonal Affective Disorder Therapeutics Market Size by Type
    • 5.4 United States Seasonal Affective Disorder Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
    • 6.2 Seasonal Affective Disorder Therapeutics Key Players in Europe
    • 6.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Type
    • 6.4 Europe Seasonal Affective Disorder Therapeutics Market Size by Application

    7 China

    • 7.1 China Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
    • 7.2 Seasonal Affective Disorder Therapeutics Key Players in China
    • 7.3 China Seasonal Affective Disorder Therapeutics Market Size by Type
    • 7.4 China Seasonal Affective Disorder Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
    • 8.2 Seasonal Affective Disorder Therapeutics Key Players in Japan
    • 8.3 Japan Seasonal Affective Disorder Therapeutics Market Size by Type
    • 8.4 Japan Seasonal Affective Disorder Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
    • 9.2 Seasonal Affective Disorder Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Type
    • 9.4 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Application

    10 India

    • 10.1 India Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
    • 10.2 Seasonal Affective Disorder Therapeutics Key Players in India
    • 10.3 India Seasonal Affective Disorder Therapeutics Market Size by Type
    • 10.4 India Seasonal Affective Disorder Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
    • 11.2 Seasonal Affective Disorder Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Seasonal Affective Disorder Therapeutics Market Size by Type
    • 11.4 Central & South America Seasonal Affective Disorder Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Allergan
      • 12.1.1 Allergan Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.1.4 Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.1.5 Allergan Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.2.4 Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Roche
      • 12.3.1 Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.3.4 Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.3.5 Roche Recent Development
    • 12.4 Eli Lily
      • 12.4.1 Eli Lily Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.4.4 Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.4.5 Eli Lily Recent Development
    • 12.5 GlaxoSmithKline
      • 12.5.1 GlaxoSmithKline Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.5.4 GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.5.5 GlaxoSmithKline Recent Development
    • 12.6 Teva Pharmaceuticals
      • 12.6.1 Teva Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.6.4 Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.6.5 Teva Pharmaceuticals Recent Development
    • 12.7 Bausch Health Companies
      • 12.7.1 Bausch Health Companies Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.7.4 Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.7.5 Bausch Health Companies Recent Development
    • 12.8 Mylan
      • 12.8.1 Mylan Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.8.4 Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.8.5 Mylan Recent Development
    • 12.9 Sanofi
      • 12.9.1 Sanofi Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.9.4 Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.9.5 Sanofi Recent Development
    • 12.10 Novartis
      • 12.10.1 Novartis Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Seasonal Affective Disorder Therapeutics Introduction
      • 12.10.4 Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
      • 12.10.5 Novartis Recent Development
    • 12.11 Johnson & Johnson
    • 12.12 Koninklijke Philips
    • 12.13 Beurer GmbH
    • 12.14 Lucimed (Luminette)

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.
      In 2018, the global Seasonal Affective Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Seasonal Affective Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Seasonal Affective Disorder Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Allergan
      Pfizer
      Roche
      Eli Lily
      GlaxoSmithKline
      Teva Pharmaceuticals
      Bausch Health Companies
      Mylan
      Sanofi
      Novartis
      Johnson & Johnson
      Koninklijke Philips
      Beurer GmbH
      Lucimed (Luminette)

      Market segment by Type, the product can be split into
      Light Therapy (Phototherapy)
      Medication
      Others

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Seasonal Affective Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Seasonal Affective Disorder Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Seasonal Affective Disorder Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now